Supportive care in cancer patients : recent developments
著者
書誌事項
Supportive care in cancer patients : recent developments
(Antibiotics and chemotherapy, vol. 50)
Karger, c2000
大学図書館所蔵 全4件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references and index
内容説明・目次
内容説明
An innovation in cancer treatment over the last decade has been the emergence of intensive chemotherapy followed by peripheral blood stem cell transplantation. The success of this intensive chemotherapy also depends on an optimal supportive care, which consists of prevention and management of adverse effects, and psychological support. This book attempts to cover the most frequent problems of supportive care in detail, especially the prevention, diagnosis and treatment of infections, adverse events in the gastrointestinal tract, and the treatment of cytotoxic drug extravasation with special consideration of recently introduced cytotoxic agents. The rational use of hematopoietic growth factors for the reversal of disease- or treatment-related neutropenia, anemia and thrombocytopenia are discussed extensively. Further issues considered include anticoagulant prophylaxis, quality of life and recent advances in the use of effective antiemetics, which have increased the tolerability of standard chemotherapy and radiotherapy, and have opened up new ways of enhancing treatment. Supportive care requires an interdisciplinary approach. This book, therefore, is designed to provide an up-to-date overview for oncologists as well as general physicians, nurses, pharmacists, and all those giving care to cancer patients.
目次
- Changing epidemiology of bacterial infection in neutropenic patients with cancer, J. Carratala and F. Gudiol
- serum and plasma parameters in clinical evaluation of neutropenic fever, Th. Sudhoff, A. Giagounidis and M. Karthaus
- antimicrobial therapy in neutropenic patients, G. Egerer, M. Karthaus, et al
- interventional once-daily administration of Ceftriaxone in leukaemia and lymphoma patients with febrile neutropenia, M. Karthaus et al
- Ceftriaxone and Cefotaxime are equally effective in the treatment of neutropenic fever, O.A. Cornely, B. Salzberger et al
- outpatient treatment of cancer patients with fever and neutropenia, M. Karthaus, G. Egerer and H. Jurgens
- current serological and molecular methods in the diagnosis of systematic infections with Candida sp. And Aspergillus sp. in immunocompromised patients with haematological malignancies, D. Buchheidt, H. Skladny et al
- antifungal prophylaxis in neutropenic patients with haematological malignancies, A. Bohme, M. Karthaus and D. Hoelzer
- treatment of systemic fungal infections in patients with haematologic malignancies, A. Bohme and M. Karthaus
- clinical use of haematopoietic growth factors, G. Seipelt
- recombitant human erythropoietin in the treatment of cancer, F. Stilgenbauer, G. Egerer et al
- new strategies in the treatment and prophylaxis of chemo- and radiotherapy-induced oral mucositis, C. Rosenthal, M. Karthaus and A. Ganser
- central venous catheter-related complications, H.-J. Salwender, G. Egerer et al
- cytotoxic drug extravasation, K. Fenchel and M. Karthaus
- anticoagulant prophylaxis and therapy in patients with cancer, M. von Depka Prondzinski, M. Karthaus et al
- quality of life assessment - problems and goals, J.G. Meran, M. Karthaus and H. Ludwig
- treatment of chemotherapy-induced emesis, G. Egerer, U. Hegenbart et al
- diarrhoea and constipation, J.T. Hartmann and C. Bokemeyer.
「Nielsen BookData」 より